Staphylococcal enterotoxins G and I, a cause of severe but reversible neonatal enteropathy

Clin Gastroenterol Hepatol. 2008 Feb;6(2):251-4. doi: 10.1016/j.cgh.2007.09.004. Epub 2007 Dec 11.

Abstract

Background & aims: Staphylococcus aureus is recognized to produce toxins A-E and toxic shock syndrome toxin-1 associated with food poisoning and toxic shock syndrome. Enterotoxins G and I co-exist in the same S aureus strains (staphylococcal enterotoxin G and staphylococcal enterotoxin I) and are implicated in scarlet fever and toxic shock. We report these enterotoxins as causative agents of 2 cases of neonatal intractable diarrhea with enteropathy.

Methods: We used a note review for this study. Stool culture, multiplex polymerase chain reaction for enterotoxin, duodenal biopsy specimens for H&E, periodic acid-Schiff staining, and electron microscopy were used.

Results: Infant 1 had diarrhea from age 2 weeks and was referred at age 5 weeks with weight less than the 0.4th percentile. Infant 2 was referred at age 7 weeks with 4 weeks' of diarrhea, weight less than the 0.4th percentile. Both infants were severely malnourished. Elemental feeds were not tolerated and total parenteral nutrition was required. S aureus producing staphylococcal enterotoxin G and staphylococcal enterotoxin I was isolated in stools from both infants. Clinical improvement occurred after intravenous flucloxacillin and parenteral nutrition. Histology showed subtotal villous atrophy (H&E) with abnormal brush border (periodic acid-Schiff). Electron microscopy showed severe microvilli destruction, dilated mitochondria, and lysosomes containing cellular debris. Repeat histology was normal in infant 2, age 3 months, off parenteral nutrition, showed return to normal. Currently, both infants are 2 years of age and are thriving on a normal diet.

Conclusions: Staphylococcal enterotoxin G- and I-induced enteropathy is a life-threatening condition, causing reversible disruption of enterocyte ultrastructure that responds well to supportive treatment with flucloxacillin and parenteral nutrition This condition should be a differential diagnosis of neonatal early onset diarrhea.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Biopsy
  • Body Weight
  • DNA, Bacterial / genetics
  • Diarrhea / drug therapy
  • Diarrhea / microbiology*
  • Enteritis / drug therapy
  • Enteritis / microbiology*
  • Enterotoxins / genetics
  • Enterotoxins / toxicity*
  • Feces / microbiology
  • Female
  • Floxacillin / therapeutic use
  • Humans
  • Infant Nutrition Disorders
  • Infant, Newborn
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / ultrastructure
  • Microscopy, Electron, Transmission
  • Parenteral Nutrition
  • Polymerase Chain Reaction / methods
  • Staphylococcal Infections / diagnosis*
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / pathology
  • Staphylococcus aureus / genetics
  • Staphylococcus aureus / isolation & purification*
  • Staphylococcus aureus / metabolism*
  • Superantigens / genetics
  • Superantigens / toxicity*

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Enterotoxins
  • Superantigens
  • enterotoxin G, staphylococcal
  • enterotoxin I, staphylococcal
  • Floxacillin